Role of Protein Misfolding in DFNA9 Hearing Loss

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Mar 16

PMID 20228067

Citations 25

Authors

Jianhua Yao

Benedicte F Py

Hong Zhu

Jianxin Bao

Junying Yuan

Affiliations

Soon will be listed here.

Abstract

Mutations in the COCH (coagulation factor C homology) gene have been attributed to DFNA9 (deafness, autosomal-dominant 9), an autosomal-dominant non-syndromic hearing loss disorder. However, the mechanisms responsible for DFNA9 hearing loss remain unknown. Here, we demonstrate that mutant cochlin, the protein product of the COCH gene, forms a stable dimer that is sensitive to reducing agent. In contrast, wild-type (WT) cochlin may form only dimers transiently. Interestingly, the presence of mutant cochlin can stabilize WT cochlin in dimer conformation, providing a possible mechanism for the dominant nature of DFNA9 mutations. Furthermore, the expression of mutant cochlin eventually induces WT cochlin to form stable oligomers that are resistant to reducing agent. Finally, we show that mutant cochlin is cytotoxic in vitro and in vivo. Our study suggests a possible molecular mechanism underlying DFNA9 hearing loss and provides an in vitro model that may be used to explore protein-misfolding diseases in general.

Citing Articles

Common genetic etiologies of sensorineural hearing loss in Koreans.

Jang S, Yoon K, Gee H Genomics Inform. 2024; 22(1):27.

PMID: 39609929 PMC: 11605866. DOI: 10.1186/s44342-024-00030-3.

Loss of drives impairments in tendon structure and function.

Adjei-Sowah E, Lecaj E, Adhikari N, Sensini C, Nichols A, Buckley M bioRxiv. 2024; .

PMID: 39605598 PMC: 11601365. DOI: 10.1101/2024.11.14.623674.

A Novel p.D544Vfs*3 Variant Associated with DFNA9 Sensorineural Hearing Loss Causes Pathological Multimeric Cochlin Formation.

Peng Y, Xiang M, Fan T, Zhong X, Dai A, Feng J Life (Basel). 2024; 14(1).

PMID: 38255649 PMC: 10817332. DOI: 10.3390/life14010033.

Interaural and sex differences in the natural evolution of hearing levels in pre-symptomatic and symptomatic carriers of the p.Pro51Ser variant in the COCH gene.

Moyaert J, Gilles A, Mertens G, Lammers M, Gommeren H, Janssens de Varebeke S Sci Rep. 2024; 14(1):184.

PMID: 38167558 PMC: 10762206. DOI: 10.1038/s41598-023-50583-6.

Construction of mouse cochlin mutants with different GAG-binding specificities and their use for immunohistochemistry.

Murakami K, Tamura R, Ikehara S, Ota H, Ichimiya T, Matsumoto N Biochem J. 2022; 480(1):41-56.

PMID: 36511224 PMC: 9987951. DOI: 10.1042/BCJ20220339.

References

Rose J, Doms R . Regulation of protein export from the endoplasmic reticulum. Annu Rev Cell Biol. 1988; 4:257-88. DOI: 10.1146/annurev.cb.04.110188.001353. View

Ferrante R . Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim Biophys Acta. 2009; 1792(6):506-20. PMC: 2693467. DOI: 10.1016/j.bbadis.2009.04.001. View

Suko T, Ichimiya I, Yoshida K, Suzuki M, MOGI G . Classification and culture of spiral ligament fibrocytes from mice. Hear Res. 2000; 140(1-2):137-44. DOI: 10.1016/s0378-5955(99)00191-4. View

Merchant S, Linthicum F, Nadol Jr J . Histopathology of the inner ear in DFNA9. Adv Otorhinolaryngol. 2000; 56:212-7. DOI: 10.1159/000059105. View

Khetarpal U . DFNA9 is a progressive audiovestibular dysfunction with a microfibrillar deposit in the inner ear. Laryngoscope. 2000; 110(8):1379-84. DOI: 10.1097/00005537-200008000-00030. View

Ikezono T, Omori A, Ichinose S, Pawankar R, Watanabe A, Yagi T . Identification of the protein product of the Coch gene (hereditary deafness gene) as the major component of bovine inner ear protein. Biochim Biophys Acta. 2001; 1535(3):258-65. DOI: 10.1016/s0925-4439(00)00101-0. View

Ohlemiller K, McFadden S, Ding D, Lear P, Ho Y . Targeted mutation of the gene for cellular glutathione peroxidase (Gpx1) increases noise-induced hearing loss in mice. J Assoc Res Otolaryngol. 2001; 1(3):243-54. PMC: 2504546. DOI: 10.1007/s101620010043. View

Liepinsh E, Trexler M, Kaikkonen A, Weigelt J, Banyai L, Patthy L . NMR structure of the LCCL domain and implications for DFNA9 deafness disorder. EMBO J. 2001; 20(19):5347-53. PMC: 125649. DOI: 10.1093/emboj/20.19.5347. View

Robertson N, Resendes B, Lin J, Lee C, Aster J, Adams J . Inner ear localization of mRNA and protein products of COCH, mutated in the sensorineural deafness and vestibular disorder, DFNA9. Hum Mol Genet. 2001; 10(22):2493-500. DOI: 10.1093/hmg/10.22.2493. View

10.

Whittaker C, Hynes R . Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol Biol Cell. 2002; 13(10):3369-87. PMC: 129952. DOI: 10.1091/mbc.e02-05-0259. View

11.

Nakagawa T, Kim T, Murai N, Endo T, Iguchi F, Tateya I . A novel technique for inducing local inner ear damage. Hear Res. 2003; 176(1-2):122-7. DOI: 10.1016/s0378-5955(02)00768-2. View

12.

Robertson N, Hamaker S, Patriub V, Aster J, Morton C . Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9. J Med Genet. 2003; 40(7):479-86. PMC: 1735525. DOI: 10.1136/jmg.40.7.479. View

13.

Grabski R, Szul T, Sasaki T, Timpl R, Mayne R, Hicks B . Mutations in COCH that result in non-syndromic autosomal dominant deafness (DFNA9) affect matrix deposition of cochlin. Hum Genet. 2003; 113(5):406-16. DOI: 10.1007/s00439-003-0992-7. View

14.

Ikezono T, Shindo S, Li L, Omori A, Ichinose S, Watanabe A . Identification of a novel Cochlin isoform in the perilymph: insights to Cochlin function and the pathogenesis of DFNA9. Biochem Biophys Res Commun. 2004; 314(2):440-6. DOI: 10.1016/j.bbrc.2003.12.106. View

15.

Rodriguez C, Cheng J, Liu L, Stewart C . Cochlin, a secreted von Willebrand factor type a domain-containing factor, is regulated by leukemia inhibitory factor in the uterus at the time of embryo implantation. Endocrinology. 2003; 145(3):1410-8. DOI: 10.1210/en.2003-1361. View

16.

Lipinski M, Yuan J . Mechanisms of cell death in polyglutamine expansion diseases. Curr Opin Pharmacol. 2004; 4(1):85-90. DOI: 10.1016/j.coph.2003.09.008. View

17.

Iguchi F, Nakagawa T, Tateya I, Endo T, Kim T, Dong Y . Surgical techniques for cell transplantation into the mouse cochlea. Acta Otolaryngol Suppl. 2004; (551):43-7. DOI: 10.1080/03655230310016816. View

18.

Bossy-Wetzel E, Schwarzenbacher R, Lipton S . Molecular pathways to neurodegeneration. Nat Med. 2004; 10 Suppl:S2-9. DOI: 10.1038/nm1067. View

19.

Glenner G, Wong C . Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984; 122(3):1131-5. DOI: 10.1016/0006-291x(84)91209-9. View

20.

Khetarpal U, SCHUKNECHT H, Gacek R, Holmes L . Autosomal dominant sensorineural hearing loss. Pedigrees, audiologic findings, and temporal bone findings in two kindreds. Arch Otolaryngol Head Neck Surg. 1991; 117(9):1032-42. DOI: 10.1001/archotol.1991.01870210104022. View